Letter to the Editor Regarding "Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023".
Saved in:
| Title: | Letter to the Editor Regarding "Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023". |
|---|---|
| Authors: | Tomeczkowski J; Institute for Evidence-Based Positioning in the Healthcare Sector, Bonn, Germany. j.tomeczkowski@dietrich.healthcare., Leverkus F; Evidence-Generating Data Evaluation, Berlin, Germany., Bussilliat P; Vfa, Berlin, Germany., Osowski U; Merck Healthcare GmbH Germany, Weiterstadt, Germany., Herrmann KH; Pharming, Ottobrunn, Germany., Eichinger B; Novartis Pharma GmbH, Nuremberg, Germany., Heidbrede T; UCB BioSciences, Monheim, Germany., Schmitter S; Pfizer Pharma GmbH, Berlin, Germany., Dietrich ES; Institute for Evidence-Based Positioning in the Healthcare Sector, Bonn, Germany., Dintsios CM; Institute for Health Services Research and Health Economics, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Bluhmki T; Bristol-Myers Squibb, Munich, Germany. |
| Source: | Advances in therapy [Adv Ther] 2025 Aug; Vol. 42 (8), pp. 4096-4101. Date of Electronic Publication: 2025 Jun 20. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40540227 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Letter to the Editor Regarding "Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023". – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tomeczkowski+J%22">Tomeczkowski J</searchLink>; Institute for Evidence-Based Positioning in the Healthcare Sector, Bonn, Germany. j.tomeczkowski@dietrich.healthcare.<br /><searchLink fieldCode="AU" term="%22Leverkus+F%22">Leverkus F</searchLink>; Evidence-Generating Data Evaluation, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Bussilliat+P%22">Bussilliat P</searchLink>; Vfa, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Osowski+U%22">Osowski U</searchLink>; Merck Healthcare GmbH Germany, Weiterstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Herrmann+KH%22">Herrmann KH</searchLink>; Pharming, Ottobrunn, Germany.<br /><searchLink fieldCode="AU" term="%22Eichinger+B%22">Eichinger B</searchLink>; Novartis Pharma GmbH, Nuremberg, Germany.<br /><searchLink fieldCode="AU" term="%22Heidbrede+T%22">Heidbrede T</searchLink>; UCB BioSciences, Monheim, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitter+S%22">Schmitter S</searchLink>; Pfizer Pharma GmbH, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Dietrich+ES%22">Dietrich ES</searchLink>; Institute for Evidence-Based Positioning in the Healthcare Sector, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Dintsios+CM%22">Dintsios CM</searchLink>; Institute for Health Services Research and Health Economics, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Bluhmki+T%22">Bluhmki T</searchLink>; Bristol-Myers Squibb, Munich, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Aug; Vol. 42 (8), pp. 4096-4101. <i>Date of Electronic Publication: </i>2025 Jun 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40540227 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-025-03269-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4096 Titles: – TitleFull: Letter to the Editor Regarding "Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023". Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tomeczkowski J – PersonEntity: Name: NameFull: Leverkus F – PersonEntity: Name: NameFull: Bussilliat P – PersonEntity: Name: NameFull: Osowski U – PersonEntity: Name: NameFull: Herrmann KH – PersonEntity: Name: NameFull: Eichinger B – PersonEntity: Name: NameFull: Heidbrede T – PersonEntity: Name: NameFull: Schmitter S – PersonEntity: Name: NameFull: Dietrich ES – PersonEntity: Name: NameFull: Dintsios CM – PersonEntity: Name: NameFull: Bluhmki T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1865-8652 Numbering: – Type: volume Value: 42 – Type: issue Value: 8 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |
